Immunocore Holdings plc
IMCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,831 | $1,578 | $1,486 | $1,475 |
| - Cash | $498 | $488 | $477 | $456 |
| + Debt | $43 | $436 | $434 | $433 |
| Enterprise Value | $1,376 | $1,527 | $1,443 | $1,452 |
| Revenue | $104 | $98 | $94 | $84 |
| % Growth | 5.8% | 4.3% | 11.7% | – |
| Gross Profit | $103 | $97 | $93 | $84 |
| % Margin | 99.5% | 98.9% | 99.1% | 99.6% |
| EBITDA | $4 | -$6 | $10 | -$15 |
| % Margin | 4% | -6.5% | 10.6% | -18.2% |
| Net Income | $1 | -$10 | $5 | -$24 |
| % Margin | 0.8% | -10.5% | 5.4% | -28.3% |
| EPS Diluted | 0.016 | -0.21 | 0.097 | -0.47 |
| % Growth | 107.4% | -316.3% | 120.7% | – |
| Operating Cash Flow | -$4 | $26 | $0 | -$14 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$4 |
| Free Cash Flow | -$5 | $26 | $0 | -$18 |